Not found in the indexed publications — check the official source.
The passages provided address savings deposits interest accrual [FMR Volume 7A, Chapter 51], missing status pay continuation [DAFMAN 65-116V1 para 51.4.8], TSP contributions [DoDI 7770.02], hazardous waste [40 CFR 261.33], family separation allowance [FMR Volume 7A, Chapter 27], clothing allowances [FMR Volume 7A, Chapter 29], and insurance allotments [FMR Volume 7A, Chapter 42], but none contains substantive regulatory content specific to your question about Volume 7A, Chapter 51 itself. To answer your question, consult the full Chapter 51 text directly.
Unofficial — answered from indexed publication text, which may be incomplete or out of date. Your MAJCOM/unit supplement may be stricter. Verify the official PDF before acting or writing a finding.
DAFMAN 65-116V1 para 51.5.2.1, p. 250 (effective/current as of 2025-08-08)t accrue while a member is in SM status. (See DoD 7000.14-R, Volume 7A, table 34-2) 51.4.8. If the member's Estimated Time of Service expires while in a missing (SM) status, pay and allowances continue per Title 37 United States Code Section 552. 51.4.9. Leave continues to accrue without regard to the normal limitations. (See DoD 7000.14- R, Volume 7A, chapter 34.) 51.5. Special Provisions: 51.5.1. Member declared dead. (See chapter 54.) 51.5.2. Member Returned to Military Control. 51.5.2.1. Continuing Management Case File. If member returns to military control before Management Case File is sent to AFPC-OL IN, the FMF having custody of Management Case File maintains it in the normal manner. Return copy of DD Form 93 to appropriate MPF or personnel activity. 51.5.2.2. Notice to AFPC-OL IN
DAFI 36-3211 para 7.1.1, p. 138 (effective/current as of 2026-02-18)l trial date has not been set the GCMCA decides whether trial should proceed or be delayed until final action is taken on the request for discharge. The GCMCA may delegate this authority to the SPCMCA. 3 trial date has been set. 4 the trial has begun (Note: Refer to DAFI 51-201, paragraph 12.32.7) the military judge decides whether trial proceeds. 5 request for discharge has been denied once trial proceeds even though reconsideration is requested. DAFI36-3211 24 JUNE 2022 99 Chapter 7 REASONS FOR INVOLUNTARY SEPARATION Section 7A—Preprocessing Considerations. 7.1. Choosing a Course of Action: a list of reasons and authority for involuntary separations is in Table 7.5. 7.1.1. Commanders and supervisors identify members who show a likelihood for early separation. They should make reasonable
No supplement passage retrieved — check the supplement chain on the pub page before citing.
DoDI 7770.02 (effective/current as of 2025-12-04)System (BRS) Automatic TSP Contribution Year to Date Amount The BRS total year to date mandatory matching contributions for TSP. Reference Chapter 51 of Volume 7A of DoD 7000.14-R. Formatted in accordance with Paragraph 3.2.b.(5). 9 Signed numeric, implied decimal Y Y Y Y 277 BRS Automatic TSP Contribution Current Month Amount The BRS current month mandatory matching contributions for TSP. Formatted in accordance with Paragraph 3.2.b.(5). 9 Signed numeric, implied decimal Y Y Y Y 278 Matching TSP Contribution Year to Date Amount The total year to date matching contributions for TSP. Reference Chapter 51 of Volume 7A of DoD 7000.14-R. Formatted in accordance with Paragraph 3.2.b.(5). 9 Signed numeric, implied decimal Y Y Y Y 279 Matching TSP Contribution Current Month Amount The current mo
40 CFR 261.33 para 261.33 (effective/current as of 2026-07-15)yrazinyl phosphorothioate P043 55-91-4 Diisopropylfluorophosphate (DFP) P004 309-00-2 1,4,5,8-Dimethanonaphthalene, 1,2,3,4,10,10-hexa- chloro-1,4,4a,5,8,8a,-hexahydro-, (1alpha,4alpha,4abeta,5alpha,8alpha,8abeta)- P060 465-73-6 1,4,5,8-Dimethanonaphthalene, 1,2,3,4,10,10-hexa- chloro-1,4,4a,5,8,8a-hexahydro-, (1alpha,4alpha,4abeta,5beta,8beta,8abeta)- P037 60-57-1 2,7:3,6-Dimethanonaphth[2,3-b]oxirene, 3,4,5,6,9,9-hexachloro-1a,2,2a,3,6,6a,7,7a-octahydro-, (1aalpha,2beta,2aalpha,3beta,6beta,6aalpha,7beta, 7aalpha)- P051 1 72-20-8 2,7:3,6-Dimethanonaphth [2,3-b]oxirene, 3,4,5,6,9,9-hexachloro-1a,2,2a,3,6,6a,7,7a-octahydro-, (1aalpha,2beta,2abeta,3alpha,6alpha,6abeta,7beta, 7aalpha)-, & metabolites P044 60-51-5 Dimethoate P046 122-09-8 alpha,alpha-Dimethylphenethylamine P191 644-64-4 Dimeti
Official source: https://www.ecfr.gov/current/title-40/section-261.33